NAMSA has acquired select assets of Labcorp’s early development medical device testing business.
The business acquisition aligns with Namsa’s strategy to broaden its service capabilities for medtech manufacturers globally.
This move adds Labcorp’s US portfolio of biocompatibility, microbiological, analytical testing, and preclinical research services to Namsa’s existing operations.
Download sample pages of selected reports
Explore a selection of report samples we have handpicked for you. Get a preview of the insights inside. Download your free copy today.
Namsa is a global provider of preclinical and clinical services, medical device testing, and regulatory consulting from facilities in the US, Asia, and Europe.
Following the acquisition, future testing and preclinical projects for former Labcorp early development medical device clients will be handled at Namsa’s sites in California, Georgia, Minnesota and Ohio.
Namsa CEO Brian Smith said: “This acquisition is a perfect fit for Namsa – we serve 3,000+ medtech companies globally in these specific areas of testing and preclinical research.
“I am confident we will be able to provide Labcorp’s medical device clients with a smooth transition, combined with the same high level of expertise and customer service current Namsa clients have come to expect from us.”
Labcorp’s early development research laboratories EVP and president Brian Caveney said: “The sale of our early development medical device testing business to Namsa allows Labcorp to focus on core areas of preclinical drug development and chemical testing. We are pleased Namsa will continue providing leading expertise to clients in this space and are committed to a seamless transition.”
This marks Namsa’s tenth acquisition since joining ARCHIMED in 2020.
In January 2025, Namsa acquired the US-based medical device testing operations of WuXi AppTec to strengthen its medtech clinical research testing capabilities.
Unlock up to 35% savings on GlobalData reports
Use the code at checkout in the report store
-
20% OFF
Buy 2 reports
Use code:
Bundle20
-
25% OFF
Buy 3 reports
Use code:
Bundle25
-
30% OFF
Buy 4 reports
Use code:
Bundle30
-
35% OFF
Buy 5+ reports
Use code:
Bundle35
Valid on all reports priced $995 and above. Cannot be combined with other offers.
Still deciding what will work best for your business?
Ask our experts for help.
Enquire before buying
